Metformin, a widely used, well-tolerated drug prescribed for patients with diabetes, may protect against liver cancer,
according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
The study, led by Geoffrey Girnun, Ph.D.,
an assistant professor in the department of biochemistry and molecular biology at the University of Maryland School of Medicine,
is one more in an ongoing look at the effect of metformin in cancer prevention.
However, it is one of the first to evaluate liver cancer.